Searching for the Novel Specific Predictors of Prostate Cancer in Urine: The Analysis of 84 miRNA Expression
Authors:
- Evgeniy A. LekchnovELEvgeniy A. Lekchnov
- Evgeniya V. AmelinaEAEvgeniya V. Amelina
- Olga E. BryzgunovaOBOlga E. Bryzgunova
- Ivan A. ZaporozhchenkoIZIvan A. Zaporozhchenko
- Mariya Yu. KonoshenkoMKMariya Yu. Konoshenko
- Sergey V. YarmoschukSYSergey V. Yarmoschuk
- Ivan S. MurashovIMIvan S. Murashov
- Oxana A. PashkovskayaOPOxana A. Pashkovskaya
- Anton M. GorizkiiAGAnton M. Gorizkii
- Aleksandr A. ZheravinAZAleksandr A. Zheravin
- Pavel P. LaktionovPLPavel P. Laktionov
Open Access
- 17 December 2018
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (12) , 4088
Abstract
The aim of this study was to investigate miRNA profiles of clarified urine supernatant and combined urine vesicle fractions of healthy donors and patients with benign prostatic hyperplasia and prostate cancer (PCa). The comparative analysis of miRNA expression was conducted with a custom miRCURY LNA miRNA qPCR panel. Significant combinations of miRNA pairs were selected by the RandomForest-based feature selection algorithm Boruta; the difference of the medians between the groups and a 95% confidence interval was built using the bootstrap approach. The Asymptotic Wilcoxon-Mann-Whitney Test was performed for miRNA combinations to compare different groups of donors. Benjamini-Hochberg correction was used to adjust the statistical significance for multiple comparisons. The most diagnostically significant miRNAs pairs were miR-107-miR-26b.5p and miR-375.3p-miR-26b.5p in the urine supernatant fraction that discriminated the group of healthy patients and PCa patients, as well as miR-31.5p-miR-16.5p, miR-31.5p-miR-200b, miR-31.5p-miR-30e.3p and miR-31.5p-miR-660.5p in the fraction extracellular vesicles that were different between healthy men and benign prostate hyperplasia patients. Such statistical criteria as the occurrence of individual significant miRNA pairs in the total number of comparisons, median ΔCt difference, and confidence interval can be useful tools for determining reliable markers of PCa.Keywords
Funding Information
- Russian Science Foundation (16-15-00124)
This publication has 48 references indexed in Scilit:
- Urinary biomarkers in prostate cancer detection and monitoring progressionCritical Reviews in Oncology/Hematology, 2017
- Urinary RNA-based biomarkers for prostate cancer detectionClinica Chimica Acta, 2017
- Liquid biopsy: a step forward towards precision medicine in urologic malignanciesMolecular Cancer, 2017
- Prostate cancer screening in Europe and AsiaAsian Journal of Urology, 2017
- The translational potential of microRNAs as biofluid markers of urological tumoursNature Reviews Urology, 2016
- Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal BiomarkersInternational Journal of Molecular Sciences, 2016
- Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic reviewMolecular Cancer, 2016
- Urinary Biomarkers for Prostate CancerUrologic Clinics of North America, 2016
- PSA and beyond: alternative prostate cancer biomarkersCellular Oncology, 2016
- A Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside PotentialJournal of Biomarkers, 2014